Cargando…
Liquid Biopsy in Early-Stage Lung Cancer: Current and Future Clinical Applications
SIMPLE SUMMARY: Early-stage disease non-small cell lung cancer has better outcomes than advanced disease, but 5-year survival rates can drop to approximately 50% in cases of increased tumor size, local extension, or nodal spread. The use of liquid biopsies to enhance diagnosis, optimize perioperativ...
Autores principales: | Vandekerckhove, Olivia, Cuppens, Kristof, Pat, Karin, Du Pont, Bert, Froyen, Guy, Maes, Brigitte |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216452/ https://www.ncbi.nlm.nih.gov/pubmed/37345038 http://dx.doi.org/10.3390/cancers15102702 |
Ejemplares similares
-
Triple Trouble: A Case of Multiple Resistance Mechanisms after First Generation EGFR-TKI in NSCLC
por: Ralki, Mike, et al.
Publicado: (2019) -
Sjögren’s Syndrome Caused by PD-1 Inhibition in a Lung Cancer Patient
por: Caeyman, Aaron, et al.
Publicado: (2023) -
The path forward in early-stage lung cancer
por: Cuppens, Kristof, et al.
Publicado: (2022) -
Diagnostic Validation of a Comprehensive Targeted Panel for Broad Mutational and Biomarker Analysis in Solid Tumors
por: Froyen, Guy, et al.
Publicado: (2022) -
Current and future applications of liquid biopsy in nonsmall cell lung cancer from early to advanced stages
por: Guibert, Nicolas, et al.
Publicado: (2020)